Cumberland Pharmaceuticals Gets FDA Approval Of Acetadote, An Antidote To Prevent Or Lessen Hepatic Injury From Acetaminophen Overdose, For Pediatric Patients
Cumberland Pharmaceuticals Gets FDA Approval Of Acetadote, An Antidote To Prevent Or Lessen Hepatic Injury From Acetaminophen Overdose, For Pediatric Patients
坎伯蘭藥業獲得FDA批准，推出解毒劑Acetadote，旨在防止或減輕兒童患者因對乙酰氨基酚過量而導致的肝損傷。
Cumberland Pharmaceuticals Gets FDA Approval Of Acetadote, An Antidote To Prevent Or Lessen Hepatic Injury From Acetaminophen Overdose, For Pediatric Patients
坎伯蘭藥業獲得FDA批准，推出解毒劑Acetadote，旨在防止或減輕兒童患者因對乙酰氨基酚過量而導致的肝損傷。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間